News and History
-
Despite global decrease, Chagas disease is rising in non-endemic regions
Read More: Despite global decrease, Chagas disease is rising in non-endemic regionsOn Nov. 6, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
-
WHO Reports Rift Valley fever in Mauritania and Senegal
Read More: WHO Reports Rift Valley fever in Mauritania and SenegalOn Nov. 5, 2025, the World Health Organization (WHO) reported that between 20 September and 30 October 2025,…
-
Colossal Biosciences Acquires Viagen, the Leader in Animal Cloning
Read More: Colossal Biosciences Acquires Viagen, the Leader in Animal CloningOn Nov. 4, 2025, Colossal Biosciences, the world’s de-extinction company, today announced its acquisition of Viagen Pets and…
-
United Therapeutics Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease
Read More: United Therapeutics Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal DiseaseOn Nov. 3, 2025, United Therapeutics, a public benefit corporation, announced the first clinical xenotransplantation in its EXPAND…
-
Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal
Read More: Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion dealOn Nov. 3, 2025, Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about…
-
CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities
Read More: CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communitiesOn Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
-
VCU researchers find explosive rise in tick-linked meat allergy across the U.S.
Read More: VCU researchers find explosive rise in tick-linked meat allergy across the U.S.On Oct. 30, 2025, researchers at Virginia Commonwealth University and VCU Health announced preliminary study findings that show…
-
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion
Read More: Thermo Fisher to buy clinical services provider Clario for up to $9.4 billionOn Oct. 29, 2025, Thermo Fisher announced it would buy privately held data management company Clario for up…
-
Lilly announces $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the U.S.
Read More: Lilly announces $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the U.S. -
Phage G genome: AI analysis maps out world’s largest cultivated bacteria-killing virus
Read More: Phage G genome: AI analysis maps out world’s largest cultivated bacteria-killing virusOn Oct. 29, 2025, University of North Carolina at Charlotte (UNC) researchers leading a multidisciplinary team across four…
-
Rice launches Brain Institute to accelerate discoveries in brain science and health
Read More: Rice launches Brain Institute to accelerate discoveries in brain science and healthOn Oct. 29, 2025, Rice University announced the creation of the Rice Brain Institute (RBI), an ambitious, interdisciplinary…
-
Lilly partners with Nvidia on AI supercomputer to speed up drug development
Read More: Lilly partners with Nvidia on AI supercomputer to speed up drug developmentOn Oct. 28, 2025, Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer…
-
Louisiana officials waited months to warn public of whooping cough outbreak
Read More: Louisiana officials waited months to warn public of whooping cough outbreakOn Oct. 28, 2025, The Louisiana Illuminator reported that when there’s an outbreak of a vaccine-preventable disease, state…
-
Qureator Achieves World’s First FDA IND Approval Using Only Human Vascularized Organoid Efficacy Data
Read More: Qureator Achieves World’s First FDA IND Approval Using Only Human Vascularized Organoid Efficacy DataOn Oct. 27, 2025, Qureator announced a major milestone, confirming a fundamental shift in drug development under the…
-
New Hampshire Man resumes dialysis after living with a gene-edited pig kidney for a record 271 days
Read More: New Hampshire Man resumes dialysis after living with a gene-edited pig kidney for a record 271 daysOn Oct. 27, 2025, a New Hampshire man resumed dialysis after living with a gene-edited pig kidney for…
-
Novartis to acquire Avidity Biosciences, an innovator in RNA therapeutics for $11 Billion
Read More: Novartis to acquire Avidity Biosciences, an innovator in RNA therapeutics for $11 BillionOn Oct. 26, 2025, Novartis announced that it has entered into an agreement to acquire Avidity Biosciences, a…
-
Study suggests two unsuspected pathogens struck Napoleon’s army during the retreat from Russia in 1812
Read More: Study suggests two unsuspected pathogens struck Napoleon’s army during the retreat from Russia in 1812On Oct. 24, 2025, scientists from the Institut Pasteur announced they have genetically analyzed the remains of former…
-
Lilly to Acquire Adverum Biotechnologies for $12.47 per Share
Read More: Lilly to Acquire Adverum Biotechnologies for $12.47 per ShareOn Oct. 24, 2025, Eli Lilly and Adverum Biotechnologies announced a definitive agreement for Lilly to acquire Adverum,…
-
Measles Outbreak Continues growing in South Carolina among Unvaccinated
Read More: Measles Outbreak Continues growing in South Carolina among UnvaccinatedAs of Oct. 24, 2025, the South Carolina Department of Public Health (DPH) reported 33 cases of measles…
-
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
Read More: Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myelomaOn Oct. 23, 2025, GSK announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf)…
